Chugai Pharmaceutical Co., Ltd. (CHGCF) Q2 2025 Earnings Call Transcript

2025-07-24 14:58:44 ET

Chugai Pharmaceutical Co., Ltd. (CHGCF)

Q2 2025 Earnings Conference Call

July 24, 2025, 04:00 AM ET

Company Participants

a - Corporate Participant

Iwaaki Taniguchi - Executive VP, Head of Finance Supervisory Division, CFO & Director

Kae Miyata - Head of Corporate Communications Department

Osamu Okuda - President, CEO & Chairman

Tsukasa Kusano - Executive VP and Head of Project & Lifecycle Management Unit

Conference Call Participants

Akinori Ueda - Goldman Sachs Group, Inc., Research Division

Fumiyoshi Sakai - UBS Investment Bank, Research Division

Hidemaru Yamaguchi - Citigroup Inc., Research Division

Kazuaki Hashiguchi - Daiwa Securities Co. Ltd., Research Division

Miki Sogi - Sanford C. Bernstein & Co., LLC., Research Division

Seiji Wakao - JPMorgan Chase & Co, Research Division

Shinichiro Muraoka - Morgan Stanley, Research Division

Tony Ren - Macquarie Research

Presentation

Kae Miyata

Thank you very much for coming over to conference on financial results for the second quarter for the year ending December 2025. I will be leading today's session. I am Miyata from Corporate Communications IR Department.

So today, we have the participants at the venue as well as on the Zoom. And today's agenda is shown on the screen at the venue as well as on Page 3 of the presentation materials. And today's conference will be conducted in Japanese, but we are also providing English on Zoom webinar as a simultaneous interpretation. [Operator Instructions] We plan on spending about half an hour for Q&A session, so feel free to ask your questions. [Operator Instructions]...

Read the full article on Seeking Alpha

For further details see: